Sometime in the next month, a retired plumber from Leeds will transfer around £3,000 to a company he has never met, in a country he has never visited, for a service that will not be finished for another six months. He will pay the balance on arrival, in person, before the work is done. If it all goes wrong, his recourse runs through a legal system operating in a language he does not read.
He is not being reckless. He is behaving exactly like the 1,398,580 people who travelled to Turkey for medical care last year, between them spending just over $3 billion according to figures from USHAŞ, the state agency that tracks this.
What makes this market worth studying is that a multi-billion-dollar industry grew up around a transaction shape our payment rails were never built for, and then solved roughly half the problem on its own.
The half it did not solve is still sitting there, unclaimed.
The bit the industry worked out by itself
Twenty years ago, a complex dental case was quoted with a consultation, then an estimate, then a series of line items that moved around as the work progressed. So the market did what enterprise software did when it got tired of billable hours. It productised.
Clinics now publish full mouth dental implants turkey package deals as fixed tiers with a headline price and a bullet list of inclusions, right down to the airport transfer and the hotel nights. It is a pricing page. It has the same architecture as a pricing page, the same psychology, and the same commercial logic.
Bundling does something else that anyone who has sold a complex product will recognise. It quietly removes the customer’s ability to price-check the components. Nobody knows what a zirconia crown should cost. Everybody knows what a hotel room costs. Wrap the two together and the comparison shopping stops at the top-line number. This is what happens to every market where the buyer purchases once in a lifetime and has no basis for judging the parts.
The bit nobody has built
Now look at the cash flows. A typical full-arch case involves a deposit, a first visit, three to six months of healing, then a second visit where the balance falls due. The patient has handed money to a foreign private company and waits half a year for delivery.
Strip out the medicine and that is an unsecured loan, extended by an individual consumer, to an overseas merchant, with no collateral and no covenant. Construction solved this with staged payments against certified progress. Property solved it with escrow. Cross-border trade solved it in the fourteenth century with the letter of credit. Elective healthcare, an industry with a larger annual turnover than plenty of listed companies, has solved it with a WhatsApp thread and a lot of goodwill.
There is an obvious product here: escrow with milestone release, where funds unlock on an uploaded post-op scan rather than on the patient’s mood. The guarantee is the other unbuilt product. In every other sector, that liability would be underwritten and reinsured by a third party. Extended warranties on washing machines get this treatment. A £12,000 irreversible surgical outcome does not.
The £100 rule that almost nobody uses
Many patients pay by bank transfer, because the clinic offers a small discount for avoiding card fees.
In doing so, UK patients hand back a statutory protection that costs them about three percent to keep. Under Section 75 of the Consumer Credit Act, a credit card issuer is jointly liable with the supplier on purchases above £100 and up to £30,000, and the House of Lords settled in 2007 that this applies to overseas transactions too.
Three percent to convert an unenforceable foreign contract into a claim against a British bank is the best-value insurance product on the market, and it is being declined daily because it looks like a fee.
Why this generalises
The lesson is that trust infrastructure lags demand by about a decade, and that the first move in any market like this is almost always commercial rather than technical. Nobody needed new technology to invent the fixed-price package. They needed someone willing to quote a number and absorb the variance, including six months of currency exposure on a lira-denominated cost base.
The same shape recurs anywhere purchases are high-ticket, cross-border, non-repeating and irreversible: fertility treatment, international tuition, bariatric surgery, custom manufacturing. In each case the money moves before the value does, and the buyer will never buy again, so reputation does almost no policing work.
Turkish clinics fixed their pricing problem years ago. The payments problem is still open, and it is worth considerably more than the teeth.
